Avacta Group (Avacta Group) Debt-to-EBITDA : -2.81 (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Avacta Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Avacta Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $21.99 Mil. Avacta Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $6.24 Mil. Avacta Group's annualized EBITDA for the quarter that ended in Jun. 2023 was $-10.03 Mil. Avacta Group's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 was -2.81.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Avacta Group's Debt-to-EBITDA or its related term are showing as below:

AVCTF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.7 Med: -0.12 Max: -0.06
Current: -0.7

During the past 13 years, the highest Debt-to-EBITDA Ratio of Avacta Group was -0.06. The lowest was -0.70. And the median was -0.12.

AVCTF's Debt-to-EBITDA is ranked worse than
100% of 278 companies
in the Biotechnology industry
Industry Median: 1.375 vs AVCTF: -0.70

Avacta Group Debt-to-EBITDA Historical Data

The historical data trend for Avacta Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avacta Group Debt-to-EBITDA Chart

Avacta Group Annual Data

Trend

Jul12

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Dec20

Dec21

Dec22

Debt-to-EBITDA

Get a 7-Day Free Trial

-0.12

-0.06

-0.66

Avacta Group Semi-Annual Data
	Jan13	Jul13	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Debt-to-EBITDA	Get a 7-Day Free Trial															-0.09	-0.05	-0.29	-0.43	-2.81

Competitive Comparison of Avacta Group's Debt-to-EBITDA

For the Biotechnology subindustry, Avacta Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avacta Group's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avacta Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Avacta Group's Debt-to-EBITDA falls into.

Avacta Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Avacta Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(24.47	+	4.571)	/	-43.878
	=	-0.66

Avacta Group's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(21.985	+	6.239)	/	-10.032
	=	-2.81

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Jun. 2023) EBITDA data.

Avacta Group (OTCPK:AVCTF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Avacta Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Avacta Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Avacta Group (Avacta Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avacta Group PLC (OTCPK:AVCTF) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

AVCT:UK RTQ1:Germany

Address

Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, GBR, LS23 7FA

Website

https://www.avacta.com

Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.